FlagshipMetabolic
Retatrutide
Triple-Agonist Research Peptide
$64.99
Retatrutide is a next-generation triple-agonist research peptide targeting GIP, GLP-1, and glucagon receptor pathways. Synthesized to the highest purity standards, it represents the flagship of the NexaPep research catalog and is intended for in-vitro and laboratory study of metabolic signaling.
Variant
Quantity
Research Applications
- Investigated in metabolic and energy-expenditure pathway models
- Studied across receptor-agonist signaling research
- Subject of ongoing comparative peptide research
For laboratory and scientific research purposes only. Not for human consumption.
Certificate of Analysis
Third-party verified — 10mg
Product FAQ
All NexaPep products are sold strictly for in-vitro laboratory and scientific research. They are not intended for human or animal consumption, diagnostics, or therapeutic use of any kind.
Yes. Every batch undergoes independent third-party analysis for identity, purity, and concentration. A Certificate of Analysis (COA) is made available for each product lot.
Our research peptides are synthesized to a minimum of 99% purity as verified by HPLC and mass spectrometry. Exact values are published on each product's COA.
Lyophilized peptides are shipped in temperature-protected packaging. For long-term stability we recommend storing unreconstituted vials at -20°C, away from light.
Lyophilized peptides require reconstitution before laboratory use. We offer sterile bacteriostatic water (0.9% benzyl alcohol) as a research supply for this purpose.
You may also research
